NYSE
$247.81▼ 1.99%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $35.95BShares out 1.500M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
23- 1d agoRegular26.10.24 01:28144Ownership#●●●#●●●
RESMED INC
Michael J. Rider, an executive at ResMed Inc., has filed an SEC Form 144 to report a proposed sale of company stock. This is a standard filing disclosing an insider's plan to dispose of shares.…more
$247.81-1.99%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.8After-hours26.10.09 06:314Ownership
RESMED INC
ResMed Inc. insider Michael J. Farrell filed a Form 4 on October 8, 2026, regarding changes in beneficial ownership of securities as of October 7, 2026. This filing formalizes the reported changes in the executive's equity holdings.…more
$247.81-1.99%vs prev closeView filingShare - 10.7After-hours26.10.08 05:22144Ownership
RESMED INC
Michael J. Farrell of ResMed Inc has filed an SEC Form 144 to report a proposed sale of company securities. This filing reflects a routine disclosure of an insider's plan to dispose of shares.…more
$247.81-1.99%vs prev closeView filingShare
22 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.1After-hours26.10.02 05:05#●●●
ResMed Announces Q1 Fiscal 2027 Earnings Release Date
ResMed plans to release its financial results for the first quarter of fiscal year 2027 on October 29, 2026, after the market closes. Management will host a webcast following the announcement to discuss the company's performance.…more
$247.81-1.99%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.1After-hours26.09.02 05:36
●●●●●●●● ●●●●● ●●●●●●
ResMed has entered into an accelerated share repurchase agreement with Citibank for $450 million. This move is part of the company's capital allocation strategy to enhance shareholder value.…more
$247.81-1.99%vs prev closeShareBenzinga - 8.27After-hours26.08.28 05:05
●●●●●●●● ●●●●● ●●●●●●
Resmed announced that its executives will attend the 24th Annual Morgan Stanley Global Healthcare Conference on September 15. As this is a standard investor relations event, it is expected to have a neutral impact on the stock price.…more
$247.81-1.99%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report